Company intelligence / Profile preview

Elastrin Therapeutics

Greenville, South Carolina, United Stateselastrin.com ↗

Ownership: Private
Employees: ~50
Development stage: Preclinical

Overview

Elastrin’s lead program uses EDTA-loaded nanoparticles conjugated with a proprietary monoclonal antibody to target and remove pathological calcification from sites of degraded elastin. The company has demonstrated preclinical efficacy in reversing vascular calcification, with plans to enter clinical trials in the near future. Their technology aims not only to halt but also reverse age-related cardiovascular disease by restoring tissue elasticity

Therapeutic areas: PulmonologyCardiovascular
Modalities: Nanoparticle drug deliveryMonoclonal antibodies (proprietary antibody-conjugated nanoparticles)Small molecules (EDTA as a chelating agent)
Industry: Biotech

Drug pipeline

3 assets

ELT-001

Preclinical

2 more assets in the full pipeline.

Request access →

Partnerships

Ongoing onboarding of medical and biotech partners; specific names not disclosed

Beyond the preview

Go deeper on Elastrin Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Elastrin Therapeutics.

Explore the full profile